Detalhe da pesquisa
1.
Diminished airway host innate response in people with cystic fibrosis who experience frequent pulmonary exacerbations.
Eur Respir J
; 63(2)2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38135443
2.
Fusobacterium nucleatum: a novel immune modulator in breast cancer?
Expert Rev Mol Med
; 25: e15, 2023 04 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37009688
3.
Cystic Fibrosis Airway Mucus Hyperconcentration Produces a Vicious Cycle of Mucin, Pathogen, and Inflammatory Interactions that Promotes Disease Persistence.
Am J Respir Cell Mol Biol
; 67(2): 253-265, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35486871
4.
Characterization of Bacteria Using Surface-Enhanced Raman Spectroscopy (SERS): Influence of Microbiological Factors on the SERS Spectra.
Anal Chem
; 94(26): 9327-9335, 2022 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35713672
5.
R othia mucilaginosa is an anti-inflammatory bacterium in the respiratory tract of patients with chronic lung disease.
Eur Respir J
; 59(5)2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34588194
6.
Antimicrobial resistance in urinary pathogens and culture-independent detection of trimethoprim resistance in urine from patients with urinary tract infection.
BMC Microbiol
; 22(1): 144, 2022 05 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35610571
7.
Taxonomic position, antibiotic resistance and virulence factor production by Stenotrophomonas isolates from patients with cystic fibrosis and other chronic respiratory infections.
BMC Microbiol
; 22(1): 129, 2022 05 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35549675
8.
Efficacy and safety of TOBI Podhaler in Pseudomonas aeruginosa-infected bronchiectasis patients: iBEST study.
Eur Respir J
; 57(1)2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32855225
9.
Anti-biofilm activity of murepavadin against cystic fibrosis Pseudomonas aeruginosa isolates.
J Antimicrob Chemother
; 76(10): 2578-2585, 2021 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34283223
10.
Murepavadin antimicrobial activity against and resistance development in cystic fibrosis Pseudomonas aeruginosa isolates.
J Antimicrob Chemother
; 76(4): 984-992, 2021 03 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33367642
11.
Characterization of clinical Ralstonia strains and their taxonomic position.
Antonie Van Leeuwenhoek
; 114(10): 1721-1733, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34463860
12.
A general protein O-glycosylation machinery conserved in Burkholderia species improves bacterial fitness and elicits glycan immunogenicity in humans.
J Biol Chem
; 294(36): 13248-13268, 2019 09 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31350337
13.
Susceptibility of Pseudomonas aeruginosa Recovered from Cystic Fibrosis Patients to Murepavadin and 13 Comparator Antibiotics.
Antimicrob Agents Chemother
; 64(2)2020 01 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-31767727
14.
Composition of airway bacterial community correlates with chest HRCT in adults with bronchiectasis.
Respirology
; 25(1): 64-70, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31364220
15.
Developing evidence-based guidance for assessment of suspected infections in care home residents.
BMC Geriatr
; 20(1): 59, 2020 02 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32059649
16.
Electronic cigarette vapour increases virulence and inflammatory potential of respiratory pathogens.
Respir Res
; 20(1): 267, 2019 Dec 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-31847850
17.
Efficacy and safety of tobramycin inhalation powder in bronchiectasis patients with P. aeruginosa infection: Design of a dose-finding study (iBEST-1).
Pulm Pharmacol Ther
; 58: 101834, 2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31433997
18.
Long-term therapy with elexacaftor/tezacaftor/ivacaftor (ETI) in cystic fibrosis: improved clinical outcomes but infection and inflammation persist.
Eur Respir J
; 62(2)2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37536727
19.
Anaerobic bacteria cultured from cystic fibrosis airways correlate to milder disease: a multisite study.
Eur Respir J
; 52(1)2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29946004
20.
"Pathogen Eradication" and "Emerging Pathogens": Difficult Definitions in Cystic Fibrosis.
J Clin Microbiol
; 56(9)2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29875191